Welcoming the status quo of the Fed, Wall Street ends up
November 2, 2023
US markets surge as earnings season exceeds expectations
November 3, 2023By Joseph Adinolf Follow and Steve GoldsteinFollow
U.S. stocks are heading for a fourth day in the green ahead of Apple earnings, Friday’s jobs report
Productivity data will be released on Thursday.
BILL PUGLIANO/AGENCE FRANCE-PRESSE/GETTY IMAGES
U.S. stocks saw gains accelerate on Thursday, with the S&P 500 on track to climb for a fourth straight session as traders cheered signs that the Federal Reserve may forego further interest-rate hikes.
What’s happening
- The Dow Jones Industrial Average DJIA gained 363 points, or 1.1%, to 33,642.
- The S&P 500 rose by 57 points, or 1.4%, to 4,294.
- The Nasdaq Composite gained 159 points, or 1.2%, to 13,222.
On Wednesday, the Dow rose 222 points, or 0.67%, to 33275, logging its biggest three-session advance since April. 3, Dow Jones Market Data show.
What’s driving markets
Wednesday’s Federal Reserve decision was still driving moves across markets on Thursday.
While the Federal Reserve left interest rates on hold as expected, investors fixated on language from Federal Reserve Chairman Jerome Powell’s policy statement where he again hinted that rising bond yields were, in fact, doing some of the Fed’s inflation-fighting job for it.
That led many investors to conclude that the central bank will likely leave rates on hold barring a significant economic downturn or reacceleration of inflationary pressures, an interpretation that has been bullish for stocks and bonds.
On Thursday, the S&P 500 looks poised to rise for a fourth day, what would be its first four-day winning streak since Oct. 11, according to FactSet data.
NOW PLAYING: How to Limit Your Debt Damage
The video player is currently playing an ad. You can skip the ad in 5 sec with a mouse or keyboard
Advertisement
“Obviously, the market is reacting positively,” Peter Cardillo, chief market economist at Spartan Capital Securities, said during a phone interview with MarketWatch.
“The fact that Powell paused for the second month in a row and basically indicated that rising yields are doing the Fed’s work by saying yields would dampen activity going forward — to me this suggests that he’s finished with the tightening cycle.”
Stocks added to their gains following a batch of favorable labor-market data released ahead of Friday’s October jobs report.
A weekly report on jobless claims showed the number of Americans who applied for unemployment benefits last week increased by 5,000 to a seven-week high of 217,000.
But strategists were more focused on a quarterly U.S. government reading on labor-market productivity, which surpassed economists’ expectations while showing that labor costs have fallen.
A 0.8% decline in unit labor costs marked the first decline since the fourth quarter of last year. Cardillo said signs of cheaper labor helped boost demand for stocks Thursday.
Treasury yields continued to slide, with the 10-year yield BX:TMUBMUSD10Y down 9.7 basis points at 4.664%, its lowest level in more than two weeks, according to FactSet data. Bond yields move inversely to prices.
After the bell, investors will receive earnings from Apple AAPL, +2.00% while they wait for Friday’s October jobs report.
They’ll be watching carefully as the “Magnificent Seven” member lays out its latest results and guidance following a batch of earlier reports from other megacap technology companies that weren’t well-received by the markets.
Finally, the Bank of England on Thursday opted to follow the Fed and hold rates steady for a second straight meeting, though the vote was closer than expected: 6-to-3 in favor of keeping rates at 5.25%.
Stocks in focus
- Shares of Palantir PLTR, 16.22% were up more than 12%.
- Tesla Inc. TSLA, 5.26% shares rose, putting them on track for their best day in a month and for a three-day win streak.
- Peloton Interactive Inc. PTON, 6.49% shares were sliding after the maker of connected exercise equipment delivered a downbeat outlook for the holiday period.
- Eli Lilly & Co. LLY, 4.73% shares rose on Thursday after the drugmaker reported a surprise third-quarter profit and strong sales growth, boosted by diabetes drug Mounjaro.
Advertisement
Partner Center
